Keywords: second-quarter, earnings, up, rhone-poulenc, french, chemicals, pharmaceuticals
Second-Quarter Earnings Up 29% At Rhone-Poulenc
Article | 30 July 1998
French chemicals and pharmaceuticals company Rhone-Poulenc achieved netincome of 1.2 billion French francs ($200.2 million), excluding non-recurring items following the listing of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
